Tamula, Richelle Mae S.
HRN: 24-79-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/11/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/11/2024
04/17/2024
IVTT
1.8g
Q6
PID, UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes